Aclaris Therapeutics, Inc. (ACRS)
4.39
-0.02
(-0.45%)
USD |
NASDAQ |
Oct 02, 16:00
4.395
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Market Cap : 613.83M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 613.83M |
| October 01, 2026 | 616.63M |
| September 30, 2026 | 735.48M |
| September 29, 2026 | 738.27M |
| September 28, 2026 | 759.25M |
| September 25, 2026 | 720.10M |
| September 24, 2026 | 752.25M |
| September 23, 2026 | 735.48M |
| September 22, 2026 | 799.80M |
| September 21, 2026 | 778.82M |
| September 18, 2026 | 769.03M |
| September 17, 2026 | 755.05M |
| September 16, 2026 | 743.87M |
| September 15, 2026 | 772.53M |
| September 14, 2026 | 788.61M |
| September 11, 2026 | 743.87M |
| September 10, 2026 | 769.73M |
| September 09, 2026 | 777.42M |
| September 08, 2026 | 847.34M |
| September 04, 2026 | 862.72M |
| September 03, 2026 | 831.95M |
| September 02, 2026 | 864.11M |
| September 01, 2026 | 841.74M |
| August 31, 2026 | 845.94M |
| August 28, 2026 | 840.34M |
| Date | Value |
|---|---|
| August 27, 2026 | 861.32M |
| August 26, 2026 | 865.51M |
| August 25, 2026 | 913.75M |
| August 24, 2026 | 882.29M |
| August 21, 2026 | 896.27M |
| August 20, 2026 | 885.09M |
| August 19, 2026 | 900.47M |
| August 18, 2026 | 881.59M |
| August 17, 2026 | 827.76M |
| August 14, 2026 | 808.18M |
| August 13, 2026 | 819.37M |
| August 12, 2026 | 816.57M |
| August 11, 2026 | 827.76M |
| August 10, 2026 | 824.96M |
| August 07, 2026 | 826.36M |
| August 06, 2026 | 851.53M |
| August 05, 2026 | 889.28M |
| August 04, 2026 | 836.15M |
| August 03, 2026 | 772.28M |
| July 31, 2026 | 726.19M |
| July 30, 2026 | 742.95M |
| July 29, 2026 | 715.02M |
| July 28, 2026 | 744.35M |
| July 27, 2026 | 749.94M |
| July 24, 2026 | 730.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 12.54B |
| Xeris Biopharma Holdings, Inc. | 1.576B |
| Alumis, Inc. | 880.26M |
| ANI Pharmaceuticals, Inc. | 1.658B |
| Veru, Inc. | 42.80M |
Market Cap Related Metrics
| PS Ratio | 69.01 |
| Price to Book Value | 4.927 |
| Price | 4.39 |
| Earnings Yield | -13.33% |